GENB
Generate Biomedicines·NASDAQ
--
--(--)
--
--(--)
3.98 / 10
Netural
Fund flow is rated good (7.95/10) with positive inflows across all investor sizes. Analysts are 40% Strong Buy and 60% Buy, yet all have zero historical win rates and the price fell 4.35%. Market sentiment is neutral, implying mixed confidence.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
40%
Buy
60%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-24
InstitutionPiper Sandler
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for GENB?
- GENB holds a Bearish analyst rating, with 60% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.98/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
